It is important to avoid this pitfall in pursuit of antimicrobial stewardship.
After the Fetch dvm360® conference in Charlotte, Dawn Boothe, DVM, MS, PhD, DACVIM, DACVCP, explained one potential area of improvement for better antimicrobial stewardship.
View the video below for the entire discussion. The following is a partial transcript.
Dawn Boothe, DVM, MS, PhD, DACVIM, DACVCP: I think [what] we have failed in most is designing the dosing regimen, because we don't really think about what it's going to take to get effective drug. And by that I mean the right drug and enough of the right drug, down to wherever that infection is beyond all the barriers of protection it has to get inside that microbe to kill it. And that is a really, really tough thing to do.
Podcast CE: A Surgeon’s Perspective on Current Trends for the Management of Osteoarthritis, Part 1
May 17th 2024David L. Dycus, DVM, MS, CCRP, DACVS joins Adam Christman, DVM, MBA, to discuss a proactive approach to the diagnosis of osteoarthritis and the best tools for general practice.
Listen